Increased amounts of von Willebrand factor are bound to microparticles after infusion of desmopressin

Haemophilia

Volumn 19, Issue 2, 2013, Pages 236-241

  Trummer, A ^a   Haarmeijer, B ^a   Werwitzke, S ^a   Wermes, C ^a   Ganser, A ^a   Budde, U ^b   Tiede, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Medilys Central Laboratory Coagulation   (Germany)

Author keywords

Haemostasis; Magnetic bead selection; Microparticles; Von Willebrand's disease

Indexed keywords

DESMOPRESSIN; PHOSPHOLIPID; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; MALE; MEMBRANE MICROPARTICLE; MICROFILTRATION; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ADHESION; THROMBOCYTE POOR PLASMA; VON WILLEBRAND DISEASE;

ADULT; ANNEXIN A5; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMOSTASIS; HEMOSTATICS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; VON WILLEBRAND DISEASE, TYPE 1; VON WILLEBRAND FACTOR; YOUNG ADULT;

EID: 84874112572     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12032     Document Type: Article

References (25)

1. Castaman G, Montgomery RR, Meschengieser SS, Haberichter SL, Woods AI, Lazzari MA. von Willebrand's disease diagnosis and laboratory issues. Haemophilia 2010; 16(Suppl. 5): 67-73.
2. Fressinaud E, Veyradier A, Sigaud M, Boyer-Neumann C, Le Boterff C, Meyer D. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. Br J Haematol 1999; 106: 777-83.
3. Favaloro EJ. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies. Semin Thromb Hemost 2006; 32: 566-76.
4. Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 59: 1272-8.
5. McGrath RT, McRae E, Smith OP, O'Donnell JS. Platelet von Willebrand factor-structure, function and biological importance. Br J Haematol 2010; 148: 834-43.
6. Coppola A, Di Minno G. Desmopressin in inherited disorders of platelet function. Haemophilia 2008; 14(Suppl. 1): 31-9.
7. Horstman LL, Valle-Riestra BJ, Jy W, Wang F, Mao W, Ahn YS. Desmopressin (DDAVP) acts on platelets to generate platelet microparticles and enhanced procoagulant activity. Thromb Res 1995; 79: 163-74.
8. Jy W, Jimenez JJ, Mauro LM et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost 2005; 3: 1301-8.
9. Morel O, Morel N, Freyssinet JM, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008; 19: 9-23.
10. Abid Hussein MN, Boing AN, Biro E et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb Res 2008; 121: 865-71.
11. Sadler JE, Budde U, Eikenboom JC et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
12. Trummer A, De Rop C, Tiede A, Ganser A, Eisert R. Recovery and composition of microparticles after snap-freezing depends on thawing temperature. Blood Coagul Fibrinolysis 2009; 20: 52-6.
13. Budde U, Schneppenheim R, Eikenboom J et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost 2008; 6: 762-71.
14. Lenting PJ, Pegon JN, Groot E, de Groot PG. Regulation of von Willebrand factor-platelet interactions. Thromb Haemost 2010; 104: 449-55.
15. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003; 1: 682-9.
16. van Schooten CJ, Denis CV, Lisman T et al. Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. Blood 2007; 109: 2430-7.
17. Keuren JF, Magdeleyns EJ, Bennaghmouch A, Bevers EM, Curvers J, Lindhout T. Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates. Br J Haematol 2007; 138: 527-33.
18. Keularts IM, Hamulyak K, Hemker HC, Beguin S. The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients. Thromb Haemost 2000; 84: 638-42.
19. Howard MA, Coghlan M, David R, Pfueller SL. Coagulation activities of plasma microparticles. Thromb Res 1988; 50: 145-56.
20. Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemost 2010; 103: 1044-52.
21. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-80.
22. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost 2008; 34: 612-34.
23. Favaloro EJ, Mohammed A, Coombs R, Mehrabani PA. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory. Br J Biomed Sci 1995; 52: 243-8.
24. Lawrie AS, Harrison P, Cardigan RA, Mackie IJ. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008; 95: 197-204.
25. Proulle V, Hugel B, Guillet B et al. Circulating microparticles are elevated in haemophiliacs and non-haemophilic individuals aged < 18 years. Br J Haematol 2005; 131: 487-9.